Back
HFA Premium Access

Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry

Session: Poster Session 3 - Drug therapy, other
Topic: Drug therapy, other
Speaker: Doctor B. Muk (Budapest, HU)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)
2 presentations
0 follower

9 more presentations in this session

Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study

Speaker: Doctor F. Hidalgo Lesmes (Cordoba, ES)

Access
Abstract
Like
Thumbnail

Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Access
Abstract
Like
Thumbnail

How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

Speaker: Doctor T. Nociarova (Brno, CZ)

Access
Abstract
Like
Thumbnail

Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure

Speaker: Professor V. Oleinikov (Penza, RU)

Access
Abstract
Slides
Like
Thumbnail

Mineralocorticoid receptor antagonists improve quality of life in patients with systolic heart failure highly treated with neurohormonal inhibitors: a propensity-score matching analysis

Speaker: Associate Professor D. Farmakis (Athens, GR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Drug therapy, other

Speakers: Doctor B. Muk, Doctor F. Hidalgo Lesmes, Doctor J. Uzokov, Doctor T. Nociarova, Professor V. Oleinikov...
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources